Host defenses in experimental scrub typhus: effect of chloramphenicol. 1977

A Shirai, and P J Catanzaro, and G H Eisenberg, and J V Osterman

The effect of chloramphenicol treatment on the development of immunity to scrub typhus in mice was studied. Chemotherapy was administered either shortly before infection and for 14 days thereafter (group I), or from 7 to 21 days postinfection (group II). Although the full course of either regimen resulted in complete protection of the mice against subsequent challenge with the homologous strain of Rickettsia tsutsugamushi, initiation of chemotherapy at 7 days postinfection resulted in more rapid development of immunity against both the original infection and subsequent challenge. In both treatment groups, a 1- to 2- day hiatus was observed between immunity to challenge in the treated animal and the ability to transfer this immunity to syngeneic recipients with lymphocyte-enriched spleen cells. Similarly, complement-fixing antibodies were not detectable until shortly after the animals were able to resist challenge. These data supported the conclusion that the rickettsiostatic effect of chloramphenicol allows the infected animal time to mount an effective immune response and, further, that initiation of chemotherapy early in the infection may delay development of this response.

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D002701 Chloramphenicol An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) Cloranfenicol,Kloramfenikol,Levomycetin,Amphenicol,Amphenicols,Chlornitromycin,Chlorocid,Chloromycetin,Detreomycin,Ophthochlor,Syntomycin
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D012285 Orientia tsutsugamushi A gram-negative, rod-shaped to coccoid bacterium. It is the etiologic agent of SCRUB TYPHUS in humans and is transmitted by mites from rodent reservoirs. Rickettsia tsutsugamushi
D012612 Scrub Typhus An acute infectious disease caused by ORIENTIA TSUTSUGAMUSHI. It is limited to eastern and southeastern Asia, India, northern Australia, and the adjacent islands. Characteristics include the formation of a primary cutaneous lesion at the site of the bite of an infected mite, fever lasting about two weeks, and a maculopapular rash. Tsutsugamushi Disease,Typhus, Scrub,Orientia tsutsugamushi Infection,Tsutsugamushi Fever,Disease, Tsutsugamushi,Diseases, Tsutsugamushi,Fever, Tsutsugamushi,Fevers, Tsutsugamushi,Infection, Orientia tsutsugamushi,Infections, Orientia tsutsugamushi,Orientia tsutsugamushi Infections,Tsutsugamushi Diseases,Tsutsugamushi Fevers
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

A Shirai, and P J Catanzaro, and G H Eisenberg, and J V Osterman
June 1986, Infection and immunity,
A Shirai, and P J Catanzaro, and G H Eisenberg, and J V Osterman
February 1978, Infection and immunity,
A Shirai, and P J Catanzaro, and G H Eisenberg, and J V Osterman
November 1979, Infection and immunity,
A Shirai, and P J Catanzaro, and G H Eisenberg, and J V Osterman
January 1982, Infection and immunity,
A Shirai, and P J Catanzaro, and G H Eisenberg, and J V Osterman
September 1980, Journal of immunology (Baltimore, Md. : 1950),
A Shirai, and P J Catanzaro, and G H Eisenberg, and J V Osterman
October 1977, Infection and immunity,
A Shirai, and P J Catanzaro, and G H Eisenberg, and J V Osterman
October 1949, The Journal of pediatrics,
A Shirai, and P J Catanzaro, and G H Eisenberg, and J V Osterman
March 1981, Infection and immunity,
A Shirai, and P J Catanzaro, and G H Eisenberg, and J V Osterman
July 1949, American journal of hygiene,
A Shirai, and P J Catanzaro, and G H Eisenberg, and J V Osterman
July 1949, American journal of hygiene,
Copied contents to your clipboard!